JP2000502328A - インダンダイマー化合物およびそれらの医薬的用途 - Google Patents
インダンダイマー化合物およびそれらの医薬的用途Info
- Publication number
- JP2000502328A JP2000502328A JP9521125A JP52112597A JP2000502328A JP 2000502328 A JP2000502328 A JP 2000502328A JP 9521125 A JP9521125 A JP 9521125A JP 52112597 A JP52112597 A JP 52112597A JP 2000502328 A JP2000502328 A JP 2000502328A
- Authority
- JP
- Japan
- Prior art keywords
- compound
- group
- groups
- ether
- equation
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
- C07C311/15—Sulfonamides having sulfur atoms of sulfonamide groups bound to carbon atoms of six-membered aromatic rings
- C07C311/20—Sulfonamides having sulfur atoms of sulfonamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atom of at least one of the sulfonamide groups bound to a carbon atom of a ring other than a six-membered aromatic ring
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C13/00—Cyclic hydrocarbons containing rings other than, or in addition to, six-membered aromatic rings
- C07C13/28—Polycyclic hydrocarbons or acyclic hydrocarbon derivatives thereof
- C07C13/32—Polycyclic hydrocarbons or acyclic hydrocarbon derivatives thereof with condensed rings
- C07C13/45—Polycyclic hydrocarbons or acyclic hydrocarbon derivatives thereof with condensed rings with a bicyclo ring system containing nine carbon atoms
- C07C13/465—Indenes; Completely or partially hydrogenated indenes
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C215/00—Compounds containing amino and hydroxy groups bound to the same carbon skeleton
- C07C215/42—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having amino groups or hydroxy groups bound to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton
- C07C215/44—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having amino groups or hydroxy groups bound to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton bound to carbon atoms of the same ring or condensed ring system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C225/00—Compounds containing amino groups and doubly—bound oxygen atoms bound to the same carbon skeleton, at least one of the doubly—bound oxygen atoms not being part of a —CHO group, e.g. amino ketones
- C07C225/20—Compounds containing amino groups and doubly—bound oxygen atoms bound to the same carbon skeleton, at least one of the doubly—bound oxygen atoms not being part of a —CHO group, e.g. amino ketones having amino groups bound to carbon atoms of rings other than six-membered aromatic rings of the carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C233/00—Carboxylic acid amides
- C07C233/01—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
- C07C233/30—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by doubly-bound oxygen atoms
- C07C233/32—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by doubly-bound oxygen atoms with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by a carbon atom of a ring other than a six-membered aromatic ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C251/00—Compounds containing nitrogen atoms doubly-bound to a carbon skeleton
- C07C251/32—Oximes
- C07C251/34—Oximes with oxygen atoms of oxyimino groups bound to hydrogen atoms or to carbon atoms of unsubstituted hydrocarbon radicals
- C07C251/44—Oximes with oxygen atoms of oxyimino groups bound to hydrogen atoms or to carbon atoms of unsubstituted hydrocarbon radicals with the carbon atom of at least one of the oxyimino groups being part of a ring other than a six-membered aromatic ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C309/00—Sulfonic acids; Halides, esters, or anhydrides thereof
- C07C309/63—Esters of sulfonic acids
- C07C309/64—Esters of sulfonic acids having sulfur atoms of esterified sulfo groups bound to acyclic carbon atoms
- C07C309/65—Esters of sulfonic acids having sulfur atoms of esterified sulfo groups bound to acyclic carbon atoms of a saturated carbon skeleton
- C07C309/66—Methanesulfonates
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C35/00—Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a ring other than a six-membered aromatic ring
- C07C35/22—Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a ring other than a six-membered aromatic ring polycyclic, at least one hydroxy group bound to a condensed ring system
- C07C35/23—Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a ring other than a six-membered aromatic ring polycyclic, at least one hydroxy group bound to a condensed ring system with hydroxy on a condensed ring system having two rings
- C07C35/32—Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a ring other than a six-membered aromatic ring polycyclic, at least one hydroxy group bound to a condensed ring system with hydroxy on a condensed ring system having two rings the condensed ring system being a (4.3.0) system, e.g. indenols
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C35/00—Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a ring other than a six-membered aromatic ring
- C07C35/48—Halogenated derivatives
- C07C35/52—Alcohols with a condensed ring system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C43/00—Ethers; Compounds having groups, groups or groups
- C07C43/02—Ethers
- C07C43/18—Ethers having an ether-oxygen atom bound to a carbon atom of a ring other than a six-membered aromatic ring
- C07C43/188—Unsaturated ethers
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
- C07C45/45—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by condensation
- C07C45/46—Friedel-Crafts reactions
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
- C07C45/51—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by pyrolysis, rearrangement or decomposition
- C07C45/511—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by pyrolysis, rearrangement or decomposition involving transformation of singly bound oxygen functional groups to >C = O groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
- C07C45/61—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups
- C07C45/62—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by hydrogenation of carbon-to-carbon double or triple bonds
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
- C07C45/61—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups
- C07C45/65—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by splitting-off hydrogen atoms or functional groups; by hydrogenolysis of functional groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
- C07C45/61—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups
- C07C45/67—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton
- C07C45/673—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton by change of size of the carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
- C07C45/61—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups
- C07C45/67—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton
- C07C45/68—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton by increase in the number of carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
- C07C45/61—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups
- C07C45/67—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton
- C07C45/68—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton by increase in the number of carbon atoms
- C07C45/70—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton by increase in the number of carbon atoms by reaction with functional groups containing oxygen only in singly bound form
- C07C45/71—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton by increase in the number of carbon atoms by reaction with functional groups containing oxygen only in singly bound form being hydroxy groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
- C07C45/61—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups
- C07C45/67—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton
- C07C45/68—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton by increase in the number of carbon atoms
- C07C45/72—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton by increase in the number of carbon atoms by reaction of compounds containing >C = O groups with the same or other compounds containing >C = O groups
- C07C45/74—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton by increase in the number of carbon atoms by reaction of compounds containing >C = O groups with the same or other compounds containing >C = O groups combined with dehydration
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C49/00—Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
- C07C49/587—Unsaturated compounds containing a keto groups being part of a ring
- C07C49/657—Unsaturated compounds containing a keto groups being part of a ring containing six-membered aromatic rings
- C07C49/665—Unsaturated compounds containing a keto groups being part of a ring containing six-membered aromatic rings a keto group being part of a condensed ring system
- C07C49/67—Unsaturated compounds containing a keto groups being part of a ring containing six-membered aromatic rings a keto group being part of a condensed ring system having two rings, e.g. tetralones
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C49/00—Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
- C07C49/587—Unsaturated compounds containing a keto groups being part of a ring
- C07C49/657—Unsaturated compounds containing a keto groups being part of a ring containing six-membered aromatic rings
- C07C49/683—Unsaturated compounds containing a keto groups being part of a ring containing six-membered aromatic rings having unsaturation outside the aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C49/00—Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
- C07C49/587—Unsaturated compounds containing a keto groups being part of a ring
- C07C49/687—Unsaturated compounds containing a keto groups being part of a ring containing halogen
- C07C49/697—Unsaturated compounds containing a keto groups being part of a ring containing halogen containing six-membered aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C49/00—Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
- C07C49/587—Unsaturated compounds containing a keto groups being part of a ring
- C07C49/753—Unsaturated compounds containing a keto groups being part of a ring containing ether groups, groups, groups, or groups
- C07C49/755—Unsaturated compounds containing a keto groups being part of a ring containing ether groups, groups, groups, or groups a keto group being part of a condensed ring system with two or three rings, at least one ring being a six-membered aromatic ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
- C07C59/40—Unsaturated compounds
- C07C59/76—Unsaturated compounds containing keto groups
- C07C59/86—Unsaturated compounds containing keto groups containing six-membered aromatic rings and other rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C65/00—Compounds having carboxyl groups bound to carbon atoms of six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
- C07C65/32—Compounds having carboxyl groups bound to carbon atoms of six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups containing keto groups
- C07C65/34—Compounds having carboxyl groups bound to carbon atoms of six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups containing keto groups polycyclic
- C07C65/36—Compounds having carboxyl groups bound to carbon atoms of six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups containing keto groups polycyclic containing rings other than six-membered aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
- C07C69/007—Esters of unsaturated alcohols having the esterified hydroxy group bound to an acyclic carbon atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
- C07C69/013—Esters of alcohols having the esterified hydroxy group bound to a carbon atom of a ring other than a six-membered aromatic ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
- C07C69/66—Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety
- C07C69/73—Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety of unsaturated acids
- C07C69/738—Esters of keto-carboxylic acids or aldehydo-carboxylic acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
- C07C69/76—Esters of carboxylic acids having a carboxyl group bound to a carbon atom of a six-membered aromatic ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
- C07C69/76—Esters of carboxylic acids having a carboxyl group bound to a carbon atom of a six-membered aromatic ring
- C07C69/84—Esters of carboxylic acids having a carboxyl group bound to a carbon atom of a six-membered aromatic ring of monocyclic hydroxy carboxylic acids, the hydroxy groups and the carboxyl groups of which are bound to carbon atoms of a six-membered aromatic ring
- C07C69/92—Esters of carboxylic acids having a carboxyl group bound to a carbon atom of a six-membered aromatic ring of monocyclic hydroxy carboxylic acids, the hydroxy groups and the carboxyl groups of which are bound to carbon atoms of a six-membered aromatic ring with etherified hydroxyl groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2602/00—Systems containing two condensed rings
- C07C2602/02—Systems containing two condensed rings the rings having only two atoms in common
- C07C2602/04—One of the condensed rings being a six-membered aromatic ring
- C07C2602/08—One of the condensed rings being a six-membered aromatic ring the other ring being five-membered, e.g. indane
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Pulmonology (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Immunology (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
Description
Claims (1)
- 【特許請求の範囲】 1.次の式の何れかの化合物を含む医薬組成物: ここで式1と3におけるR1及びR3からR15まで;並びに式2と4におけるR2 からR15までは、次に示すものの1つ又はそれらの同一または異なる2つ以上か ら選ばれたものであり、 H、ハロ、ヒドロキシ、アルコキシ、アリルオキシ、アセトキシ、カルボキシ 、アルキルカルボニル、ヒドロカルボニル、アミノ、アミド、アルキルアミノ、 ヒドロキシアミノ、アミンオキサイド基、アゾ基、シアノ、ヒドラジノ基、ヒド ラジド基、ヒドラゾン基、イミド基、イミノエーテル基、ウレイル基、オキシム 、ニトロ、ナイトレート、ナイトライ ト、ニトロソ基、ニトリル、N,O又はSの1つ以上から選ばれたヘテロ原子を 含むヘテロ環状基、アラルキル基、モノ及びポリベンゾイドアリル基、置換アリ ル基、チオール、チオウレイル、フェニルチオール基、スルホン酸基、スルホキ サイド基、スルホン基、飽和でも不飽和でもよい1から10の炭素原子を含むア ルキル若しくは3から8の炭素原子を含むシクロアルキル基、並びに飽和でも不 飽和でもよい置換アルキル若しくはシクロアルキルで; 式1と4において、R8とR15;又はR8とR9の何れかは一緒になって二重結合 を表わしてもよく; 式2と3において、R8とR15;又はR8とR9;又はR8とR14の何れかは一緒 になって二重結合を表わしてもよく; 式1において、R1、1R1;R3、1R3;R9、1R9、R10、1R10の1つ又はそ れ以上の何れかは一緒になってオキソを表わしてもよく; 式2において、R2、1R2;R3、1R3;R9、1R9;R14、1R14の1つ又はそ れ以上の何れかは一緒になってオキソを表わしても良く; 式3において、R1、1R1;R3、1R3;R9、1R9;R14、1R14の1つ又はそ れ以上の何れかは一緒になってオキソを表わしてもよく; 式4において、R2、1R2;R3、1R3;R9、1R9;R10、1R10の1つ又はそ れ以上の何れかは一緒になってオキソを表わしても良い。 2.請求項1に記載されるた式1から4の何れかの化合物。 3.式1においてR1、1R1;R3、1R3;及びR10、1R10の全てが一緒 になってオキソを表わすものでない請求項2記載の化合物。 4.式2においてR3、1R3;R9、1R9;及びR14、1R14の全てが一緒 になってオキソを表わすものでない請求項2の化合物。 5.式3において、R1、1R1;R3、1R3;R9、1R9;及びR14、1R14 のうち3つ又は4つ全てが一緒になってオキソを表わすものでない請求項2の化 合物。 6.式4において、R1、1R1;R3、1R3;R9、1R9;及びR14、1R14 のうち3つ又は4つ全てが一緒になってオキソを表わすものでない請求項2の化 合物。 7.アルキル又はシクロアルキルが1つ又はそれより多い同一又は異なる ハロ、オキソ、ヒドロキシ、アルコキシ、アリルオキシ、アセトキシ、カルボキ シ、カルボニル、アミノ、アミド、アルキルアミノ、ヒドロキシアミノ、アミン オキサイド基、アゾ基、シアノ、ヒドラジノ基、ヒドラジド基、ヒドラゾン基、 イミド基、イミノエーテル基、ウレイル基、オキシム、ニトロ、ナイトレート、 ナイトライト、ニトロソ基、ニトリル、ヘテロ環状基、アラルキル基、モノ及び ポリベンゾイドアリル基、置換アリル基、チオール、チオウレイル、フェニルチ オール基、スルホン酸基、スルホキサイド基並びにスルホン基で置換されている 請求項2乃至請求項6の何れかに記載の化合物。 8.ヘテロ環状基が、1つ以上のN,O又はSを含むヘテロ原子から選ば れたもの である請求項2乃至請求項7の何れかに記載の化合物。 9.式1のR3からR7までが水素である請求項2乃至請求項8の何れかに 記載の化合物。 10.式1のR10からR14までが水素である請求項2乃至請求項9までの 何れかに記載の化合物。 11.1のR8とR9が一緒になって二重結合を表わす請求項2乃至請求項1 0の何れかに記載の化合物。 12.式1のR1、1R1がH,OHを表わす請求項2乃至請求項11の何れか に記載の化合物。 13.式1のR15がベンジル基を表わす請求項2乃至請求項12の何れかに 記載の化合物。 14.式2のR3からR7が水素である請求項2乃至請求項8の何れかに記 載の化合物。 15.式2のR10からR13が水素である請求項2乃至請求項8又は請求項1 4の何れかに記載の化合物。 16.式2のR8とR9又はR8とR9が一緒になって二重結合を表わす請求 項2乃至請求項8、請求項14又は請求項15の何れかに記載の化合物。 17.式2のR2と1R2がH,OHを表わす請求項2乃至請求項8又は請求 項14乃至請求項16の何れかに記載の化合物。 18.式2のR15がベンジル基を表わす請求項2乃至請求項8又は請求項1 4乃至請求項17の何れかに記載の化合物。 19.式2のR4からR7までが水素を表わす請求項2乃至請求項8の何れ かに記載の化合物。 20.式3のR10からR13までが水素を表わす請求項2乃至請求項8又は 請求項19の何れかに記載の化合物。 21.式3のR8とR9又はR8とR14が一緒になって二重結合を表わす請求 項2乃至請求項8、請求項19又は請求項20の何れかに記載の化合物。 22.式3のR1と1R1がH,OHを表わす請求項2乃至請求項8又は請求 項19乃至請求項21の何れかに記載の化合物。 23.式3のR15がベンジル基を表わす請求項2乃至請求項8又は請求項1 9乃至請求項22の何れかに記載の化合物。 24.式4のR4からR7までが水素を表わす請求項2乃至請求項8の何れ かに記載の化合物。 25.式4のR10からR14までが水素を表わす請求項2乃至請求項8又は 請求項24の何れかに記載の化合物。 26.本明細書中の付録2に記載の化合物の何れかから選ばれた化合物。 27.本明細書の実施例において実質的に記載された化合物。 28.請求項2乃至請求項27の何れかの化合物と医薬的に許容される担体 とを含む医薬組成物。 29.本明細書の実施例において実質的に記載された医薬組成物。 30.請求項2乃至請求項27の何れかに記載された式1から4の何れかの 化合物の、平滑筋弛緩活性及び/又はマスト細胞安定化活性及び/又は抗炎症活性 を得るための用途。 31.請求項2乃至請求項27の何れかに記載された式1から4の何れかの 化合物の、マスト細胞安定化活性を得るための用途。 32.請求項2乃至請求項27の何れかに記載された式1から4の何れかの 化合物の、抗炎症活性を得るための用途。 33.実施例においてこれまでに実質的に記載の用途。 34.平滑筋弛緩活性及び/又はマスト細胞安定化活性及び/又は抗炎症活 性を得るべく請求項2乃至請求項27の何れかに記載された式1から4の何れかの 化合物。 35.請求項2乃至請求項27の何れかに記載された式1から4の何れかの 化合物の有効量を患者に投与することにより平滑筋弛緩活性及び/又はマスト細 胞安定化活性及び/又は抗炎症活性を得るための予防または治療方法。 36.インダン1-オンとアルミニウムトリ-tert-ブトキサイトを反応させ ることによる請求項2の化合物の製造方法。 37.特にリチウムジイソプロピルアミド又はカリウムtert-ブトキサイド を用いてα,β-エノンをアルキル化してα-アルキル-β,α-エノンとする請求項 2の化合物の製造方法。 38.特に触媒、中でも塩酸のような濃厚な水性酸を含んでも良い活性炭 上のパラジウムを用いて二重結合及び/又はケトン官能基を還元する請求項2の 化合物の製造方法。 39.ホウ水素化ナトリウムを用いてケトン官能基を還元する請求項2の 化合物の製造方法。 40.ヒドラジン水和物を用いてケトン官能基を還元する請求項2の化合 物の製造方法。 41.シアノホウ水素化ナトリウムを用いてケトン官能基を還元する請求 項2の化合物の製造方法。 42.活性炭上の5%パラジウムでα,β-エノン二重結合の還元または異性 化を行う請求項2の化合物の製造方法。 43.ウイルキンソン触媒を用いて5員環の外部のC=Cを還元する請求 項2の化合物の製造方法。 44.ルイス酸を用いてインダノンのシリルエノールエーテルを、同一ま たは異なるインダノンの対応するジメチルアセタールとカップリングさせる請求 項2の化合物の製 造方法。 45.ルイス酸がTMSトリフレートである請求項44の方法。 46.異なるインダノンのシリルエノールエーテルとジメチルアセタール のカップリングで生成したメチルエーテルからメタノールを除去する工程を含む 請求項44または請求項45の方法。 47.メタノールがトリフリン酸の添加により除去される請求項46の方法 。 48.ルイス酸を用いて3-ブロモインダン-1-オンをシリルエノールエーテ ルヘカップリングさせることを含む請求項2の化合物の製造方法。 49.ルイス酸がTMSトリフレートである請求項48の方法。 50.リチウムトリtert-ブトキシアルミノハイドライド又はリチウムア ルミニウムハイドライドを用いてケトン官能基を還元する請求項2の化合物の製 造方法。 51.ルイス酸を用いてインダノンのシリルエノールエーテルを1-インダ ノンの対応する環状ケタール又は適当なカルボニル化合物とカップリングさせる 請求項2の化合物の製造方法。 52.ルイス酸がTMSトリフレートである請求項51項の方法。 53.3-ブロモインダノンを1及び2-アミノインダンとカップリングさせ る請求項2の化合物の製造方法。 54.カップリング生産物のN-アルキル化またはN-アシル化の過程を含む 請求項53の方法。 55.メタンスルホン酸クロライド又はメタンスルホン酸無水物を用いる1 -インダノールの自己カップリングによる請求項2の化合物の製造方法。 56.請求項2項の化合物のアルコール官能基のアセチル化による請求項 2の化合物の製造方法。 57.塩基としてピリジン又は酢酸ソーダと共に、特にヒドロキシルアミ ン塩酸塩を用いてオキシムを形成することによる請求項2項の化合物、特に請求 項2の水溶性化合物の製造方法。 58.tert-ブトキシドリチウムまたはジイソプロピルアミドリチウムのい ずれかを塩基として用いるオキシム官能基のO-アルキル化の過程を包含する請求 項55記載の製法。 59.リチウムN-ブチルを塩基として用いるベンジルオキシムエーテルの α-アルキル化の過程を包含する請求項56記載の製法。 60.水素化アルミニウムリチウムを還元剤として用いるO-ベンジルオキ シムエーテルを還元する過程を包含する請求項57記載の製法。 61.実質的に本明細書中の実施例に記載された式7または8の化合物の 調製方法。 62.請求項34〜59のいずれかの製法により調製された式7または8の化 合物。 63.本明細書中の実施例に記載の新規な中間体。
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IE950922 | 1995-12-06 | ||
IE950922 | 1995-12-06 | ||
IE960762 | 1996-10-31 | ||
IE960762 | 1996-10-31 | ||
PCT/IE1996/000080 WO1997020802A1 (en) | 1995-12-06 | 1996-12-06 | Indane dimer compounds and their pharmaceutical use |
Publications (1)
Publication Number | Publication Date |
---|---|
JP2000502328A true JP2000502328A (ja) | 2000-02-29 |
Family
ID=26319864
Family Applications (3)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP9521127A Ceased JP2000506497A (ja) | 1995-12-06 | 1996-12-06 | 平滑筋弛緩活性および/またはマスト細胞安定化活性および/または抗炎症活性を有するインダン化合物 |
JP9521125A Ceased JP2000502328A (ja) | 1995-12-06 | 1996-12-06 | インダンダイマー化合物およびそれらの医薬的用途 |
JP9521126A Ceased JP2000502072A (ja) | 1995-12-06 | 1996-12-06 | 平滑筋弛緩および/または肥満細胞安定化および/または抗炎症作用を有するインダンダイマー(二量体)化合物 |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP9521127A Ceased JP2000506497A (ja) | 1995-12-06 | 1996-12-06 | 平滑筋弛緩活性および/またはマスト細胞安定化活性および/または抗炎症活性を有するインダン化合物 |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP9521126A Ceased JP2000502072A (ja) | 1995-12-06 | 1996-12-06 | 平滑筋弛緩および/または肥満細胞安定化および/または抗炎症作用を有するインダンダイマー(二量体)化合物 |
Country Status (13)
Country | Link |
---|---|
US (3) | US6300376B1 (ja) |
EP (3) | EP0874800B1 (ja) |
JP (3) | JP2000506497A (ja) |
KR (2) | KR19990072007A (ja) |
AT (3) | ATE246670T1 (ja) |
AU (3) | AU1169397A (ja) |
CA (2) | CA2239853C (ja) |
DE (3) | DE69629387T2 (ja) |
DK (1) | DK0865419T3 (ja) |
GB (3) | GB2323088A (ja) |
IE (1) | IE960865A1 (ja) |
IL (3) | IL124795A (ja) |
WO (3) | WO1997020802A1 (ja) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2014524921A (ja) * | 2011-07-22 | 2014-09-25 | ヴェナンティウス・リミテッド | 炎症性腸疾患の治療に使用するためのインデン誘導体 |
Families Citing this family (20)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU2458697A (en) | 1996-04-18 | 1997-11-07 | Alcon Laboratories, Inc. | Calcium channel blockers as human conjunctival mast cell degranulation inhibitors for treating ocular allergic conditions |
AU8031698A (en) * | 1997-06-05 | 1998-12-21 | Venantius Limited | Indane compounds and their pharmaceutical use |
JP2001064202A (ja) * | 1999-08-25 | 2001-03-13 | Kissei Pharmaceut Co Ltd | 心不全予防治療剤 |
DE10142660A1 (de) * | 2001-08-31 | 2003-03-20 | Aventis Pharma Gmbh | Verwendung von Derivaten von C2-substituierten Indan-1-ol-Systemen zur Herstellung von Medikamenten zur Prophylaxe oder Behandlung von Obesitas |
DE10142663B4 (de) * | 2001-08-31 | 2004-08-19 | Aventis Pharma Deutschland Gmbh | C2-Disubstituierte Indan-1-ol-Systeme |
DE10142661B4 (de) | 2001-08-31 | 2004-06-09 | Aventis Pharma Deutschland Gmbh | Mehrfach substituierte Indan-1-ol-Systeme und ihre Verwendung als Arzneimittel |
DE10142666A1 (de) * | 2001-08-31 | 2003-03-20 | Aventis Pharma Gmbh | Verwendung von C2-substituierten Indan-1-ol-Systemen zur Herstellung von Medikamenten zur Prophylaxe oder Behandlung von Obesitas |
DE10142662B4 (de) * | 2001-08-31 | 2004-07-08 | Aventis Pharma Deutschland Gmbh | Derivate von C2-substituierten Indan-1-ol-Systemen und ihre Verwendung als Arzneimittel |
DE10142659A1 (de) | 2001-08-31 | 2003-03-20 | Aventis Pharma Gmbh | Verwendung von mehrfach substituierten Indan-1-ol. Systemen zur Herstellung von Medikamenten zur Prophylaxe oder Behandlung von Obesitas |
DE10142668A1 (de) * | 2001-08-31 | 2003-03-20 | Aventis Pharma Gmbh | Verwendung von C2-substituierten Indan-1-on-Systemen zur Herstellung von Medikamenten zur Prophylaxe oder Behandlung von Obesitas |
DE10142667B4 (de) | 2001-08-31 | 2004-06-09 | Aventis Pharma Deutschland Gmbh | C2-substituierte Indan-1-ole und ihre Derivate und ihre Verwendung als Arzneimittel |
DE10142665B4 (de) | 2001-08-31 | 2004-05-06 | Aventis Pharma Deutschland Gmbh | C2-Disubstituierte Indan-1-one und ihre Derivate |
DE10142722A1 (de) | 2001-08-31 | 2003-03-27 | Aventis Pharma Gmbh | C2-substituierte Indan-1-one und ihre Derivate, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel |
US10517839B2 (en) * | 2008-06-09 | 2019-12-31 | Cornell University | Mast cell inhibition in diseases of the retina and vitreous |
TWI537245B (zh) * | 2011-07-22 | 2016-06-11 | 維南提亞有限公司 | 用於治療自體免疫發炎疾病之化合物 |
US9260376B2 (en) | 2011-07-22 | 2016-02-16 | Venantius Limited | Compounds for use in the treatment of immune related inflammatory disease |
EP2855416A1 (en) * | 2012-05-24 | 2015-04-08 | Venantius Limited | Indane dimers for use in the treatment of autoimmune inflammatory disease |
EP2864279B1 (en) | 2012-05-24 | 2016-11-02 | Venantius Limited | Compounds for use in the treatment of autoimmune inflammatory disease |
WO2020205455A1 (en) * | 2019-03-29 | 2020-10-08 | Taiwanj Pharmaceuticals, Co., Ltd. | Peripheral alkyl and alkenyl chains extended benzene derivatives and pharmaceutical composition including the same |
CN111533764B (zh) * | 2020-05-12 | 2023-06-06 | 杭州师范大学 | 一种利用多米诺反应制备硅氧基茚衍生物的方法 |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE1205537B (de) * | 1961-08-19 | 1965-11-25 | Thomae Gmbh Dr K | Verfahren zur Herstellung neuer Steroidester |
US3668258A (en) * | 1969-03-17 | 1972-06-06 | Uniroyal Inc | Sulfur-containing polyaryl polyphenolic compounds and process |
SE421305B (sv) * | 1973-10-12 | 1981-12-14 | Merck & Co Inc | Forfarande for framstellning av 1-hydroxi-5-indanyloxiettiksyror |
-
1996
- 1996-12-06 WO PCT/IE1996/000080 patent/WO1997020802A1/en active IP Right Grant
- 1996-12-06 GB GB9812213A patent/GB2323088A/en not_active Withdrawn
- 1996-12-06 EP EP96942551A patent/EP0874800B1/en not_active Expired - Lifetime
- 1996-12-06 EP EP96942552A patent/EP0873301B1/en not_active Expired - Lifetime
- 1996-12-06 AU AU11693/97A patent/AU1169397A/en not_active Abandoned
- 1996-12-06 IL IL12479596A patent/IL124795A/xx not_active IP Right Cessation
- 1996-12-06 CA CA002239853A patent/CA2239853C/en not_active Expired - Fee Related
- 1996-12-06 JP JP9521127A patent/JP2000506497A/ja not_active Ceased
- 1996-12-06 AT AT96942551T patent/ATE246670T1/de not_active IP Right Cessation
- 1996-12-06 AT AT96942550T patent/ATE246668T1/de not_active IP Right Cessation
- 1996-12-06 KR KR1019980704299A patent/KR19990072007A/ko not_active Application Discontinuation
- 1996-12-06 JP JP9521125A patent/JP2000502328A/ja not_active Ceased
- 1996-12-06 DE DE69629387T patent/DE69629387T2/de not_active Expired - Lifetime
- 1996-12-06 AU AU11692/97A patent/AU724648B2/en not_active Ceased
- 1996-12-06 DE DE69631688T patent/DE69631688T2/de not_active Expired - Fee Related
- 1996-12-06 JP JP9521126A patent/JP2000502072A/ja not_active Ceased
- 1996-12-06 IE IE960865A patent/IE960865A1/en not_active IP Right Cessation
- 1996-12-06 IL IL12475696A patent/IL124756A0/xx active IP Right Grant
- 1996-12-06 DE DE69629390T patent/DE69629390T2/de not_active Expired - Fee Related
- 1996-12-06 AT AT96942552T patent/ATE260241T1/de not_active IP Right Cessation
- 1996-12-06 WO PCT/IE1996/000082 patent/WO1997020806A1/en active IP Right Grant
- 1996-12-06 WO PCT/IE1996/000081 patent/WO1997020805A1/en active IP Right Grant
- 1996-12-06 DK DK96942550T patent/DK0865419T3/da active
- 1996-12-06 CA CA002239694A patent/CA2239694C/en not_active Expired - Lifetime
- 1996-12-06 GB GB9812215A patent/GB2322858A/en not_active Withdrawn
- 1996-12-06 EP EP96942550A patent/EP0865419B1/en not_active Expired - Lifetime
- 1996-12-06 KR KR1019980704269A patent/KR19990071978A/ko not_active Application Discontinuation
- 1996-12-06 GB GB9812216A patent/GB2322859A/en not_active Withdrawn
- 1996-12-06 AU AU11691/97A patent/AU1169197A/en not_active Abandoned
-
1998
- 1998-06-04 IL IL124756A patent/IL124756A/en not_active IP Right Cessation
- 1998-06-08 US US09/093,060 patent/US6300376B1/en not_active Expired - Lifetime
- 1998-06-08 US US09/092,903 patent/US6423752B1/en not_active Expired - Fee Related
- 1998-06-08 US US09/092,902 patent/US6297399B1/en not_active Expired - Fee Related
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2014524921A (ja) * | 2011-07-22 | 2014-09-25 | ヴェナンティウス・リミテッド | 炎症性腸疾患の治療に使用するためのインデン誘導体 |
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP2000502328A (ja) | インダンダイマー化合物およびそれらの医薬的用途 | |
JP2000500479A (ja) | ピラゾール誘導体、その製造方法、および該誘導体を含む医薬組成物 | |
JP2006511596A (ja) | β−2アゴニストとしてのインドール誘導体 | |
KR970005302B1 (ko) | 이미다조피린딘 혈소판 활성 인자/히스타민(paf/h₁)길항제 | |
JPH0680566A (ja) | ロイコトリエンアンタゴニストとして有用な1,2,4−トリ酸素化ベンゼン誘導体 | |
JPH10182583A (ja) | 新規ヒドロキサム酸誘導体 | |
JP2001501202A (ja) | ロイコトリエンb4(ltb―4)レセプターアンタゴニスト活性によるアリル置換アクリルアミド | |
JPH10500106A (ja) | 治療物質としての置換された縮合および橋かけ二環式化合物 | |
US6362211B2 (en) | Polycyclic indanylimidazoles with alpha2 adrenergic activity | |
US6433021B1 (en) | Indane compounds and their pharmaceutical use | |
JPWO2017170859A1 (ja) | ビスアリール誘導体及びその医薬用途 | |
JPH08175992A (ja) | 神経成長因子産生促進剤および縮環型オキサゾール化合物 | |
JP2006504792A (ja) | I.a.hivの治療における逆転写酵素変調剤として使用の4−(3,5−ジシアノフェノキシ)ピラゾール誘導体 | |
US5789432A (en) | Aromatase-inhibiting composition containing azole derivative | |
JPH0560462B2 (ja) | ||
JPH05339234A (ja) | ヘキサヒドロインデノ〔1,2−b〕ピロール誘導体 | |
JP2755673B2 (ja) | 炭素環式化合物、その製造法、中間体、およびロイコトリエン拮抗作用を有する製薬学的組成物 | |
JP2002507983A (ja) | (1h−イミダゾール−4−イル)ピペリジン誘導体、それらの製造およびそれらの治療における応用 | |
JPS6219552A (ja) | 3−〔(4−アロイル)フエノキシ(またはフエニルチオ)〕シクロペンタンカルボン酸誘導体、それらの製造方法及びそれらを有効成分として含有する脳浮腫治療剤 | |
Nugent et al. | Competing pathways of phenonium ion formation and neutralization in the formolysis of isomeric 2-(4-[2.2] paracyclophanyl) propyl tosylates | |
JP2002538134A (ja) | 療法に有用な1,2,3,4−テトラヒドロ−1−ナフタレンアミン化合物 | |
JPH06312987A (ja) | ピラゾール縮合環誘導体 | |
JPH0995475A (ja) | ベンゾシクロアルケン類、その製造法および剤 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20031205 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20061024 |
|
A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20070124 |
|
A602 | Written permission of extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A602 Effective date: 20070312 |
|
A313 | Final decision of rejection without a dissenting response from the applicant |
Free format text: JAPANESE INTERMEDIATE CODE: A313 Effective date: 20070606 |
|
A02 | Decision of refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A02 Effective date: 20070717 |